IFI30 and glioma: Liu et al. found the expression of IFI30 to be high in glioblastomas and in gliomas with a mesenchymal subtype or wild-type isocitrate dehydrogenase, all of which indicated the malignancy and poor outcomes of glioma (Liu et al., 2020).